TABLE 2.
Relationships between the expressions of the IRGs and the clinicopathological characteristics in endometrial cancer.
| Id | Age | Stage | Grade | BMI | Pregnancies | Tamoxifen | Pharmaceutical | Diabetes | Hypertension | Radiation |
| t(p) | t(p) | t(p) | t(p) | t(p) | t(p) | t(p) | t(p) | t(p) | t(p) | |
| LTA | 0.908 (0.364) | 2.775 (0.006) | −0.665 (0.507) | 0.584 (0.561) | 0.051 (0.959) | −0.384 (0.714) | 0.354 (0.725) | 0.351 (0.726) | −0.705 (0.481) | −0.26 (0.795) |
| PSMC4 | −1.329 (0.184) | −2.344 (0.020) | −4.647 (5.004e−06) | −0.321 (0.749) | −1.626 (0.106) | −0.153 (0.882) | 0.062 (0.951) | 0.022 (0.982) | −1.175 (0.241) | −1.446 (0.150) |
| KAL1 | −2.104 (0.036) | −1.024 (0.307) | −1.559 (0.120) | −2.168 (0.032) | −0.839 (0.403) | −1.101 (0.313) | −0.397 (0.693) | −0.536 (0.593) | 0.088 (0.930) | −0.509 (0.611) |
| TNF | −2.04 (0.042) | −1.555 (0.122) | −1.91 (0.057) | 0.44 (0.661) | −0.712 (0.477) | −0.886 (0.410) | −1.937 (0.058) | −1.535 (0.127) | −0.468 (0.640) | 0.647 (0.518) |
| SBDS | −0.653 (0.514) | −3.11 (0.002) | −7.062 (6.468e−12) | 1.414 (0.162) | −0.376 (0.707) | 1.142 (0.294) | −0.28 (0.780) | 2.266 (0.024) | 2.271 (0.024) | −1.578 (0.115) |
| HDGF | −3.582 (3.826e−04) | −3.583 (4.11e−04) | −8.674 (6.483e−17) | 1.154 (0.251) | −1.512 (0.132) | −0.69 (0.515) | −1.805 (0.076) | 1.174 (0.242) | 0.528 (0.597) | −1.28 (0.201) |
| LTB | −1.397 (0.163) | −0.288 (0.773) | −0.715 (0.475) | 0.823 (0.413) | 0.72 (0.472) | −0.882 (0.411) | −0.218 (0.828) | 0.306 (0.760) | 0.951 (0.342) | 1.553 (0.121) |
| HTR3E | 0.9 (0.369) | −1.025 (0.307) | −1.06 (0.290) | −1.06 (0.290) | 1.053 (0.293) | 0.511 (0.611) | 0.873 (0.383) | 1.017 (0.310) | 0.814 (0.416) | −0.98 (0.328) |
| NR2F1 | 1.173 (0.242) | 0.118 (0.906) | −1.776 (0.077) | 0.858 (0.393) | 0.953 (0.341) | 0.511 (0.626) | 1.934 (0.056) | 0.24 (0.811) | 0.876 (0.382) | 0.023 (0.982) |
| NR3C1 | −1.703 (0.090) | −3.071 (0.002) | −5.572 (4.443e−08) | 1.248 (0.216) | −0.612 (0.541) | −1.169 (0.286) | −1.606 (0.113) | −0.234 (0.815) | 0.705 (0.481) | −1.204 (0.230) |
| PGR | 4.139 (4.121e−05) | 5.709 (2.527e−08) | 8.551 (3.876e−16) | −4.745 (5.258e−06) | 0.449 (0.654) | 4.321 (0.003) | 4.974 (3.228e−06) | −2.129 (0.035) | −1.698 (0.090) | 0.865 (0.387) |
| CBLC | −1.752 (0.081) | −1.01 (0.314) | −1.915 (0.056) | −0.431 (0.667) | −0.266 (0.790) | −0.331 (0.750) | −0.139 (0.890) | 0.031 (0.976) | 1.097 (0.273) | 0.107 (0.915) |
| riskScore | 1 (0.318) | −1 (0.319) | −1 (0.318) | −1 (0.318) | 1 (0.318) | 1 (0.318) | 1 (0.318) | 1 (0.318) | 1 (0.318) | −1 (0.319) |
t, t-value of student’s t-test; P, P−value of student’s t-test.